FMI Insider Trading Activity and SEC Form 4 Filings
FMI insider trading summary
No open-market insider purchases or sales of Foundation Medicine, Inc. (FMI) have been reported on SEC Form 4 in the past 12 months.
Latest FMI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 31, 2018 | Roche Holding Ltd | Director | Buy | $321.0M (2,343,078 @ $137.00) |
| Jul 31, 2018 | Roche Holding Ltd | Director | Buy | $1.90B (13,877,949 @ $137.00) |
| Jul 31, 2018 | Roche Finance Ltd | Director | Buy | $321.0M (2,343,078 @ $137.00) |
| Jul 31, 2018 | Roche Finance Ltd | Director | Buy | $1.90B (13,877,949 @ $137.00) |
| Jul 31, 2018 | Roche Holdings Inc | Director | Buy | $1.90B (13,877,949 @ $137.00) |
| Jul 31, 2018 | Roche Holdings Inc | Director | Buy | $321.0M (2,343,078 @ $137.00) |
| Jul 2, 2018 | Jason Ryan | Chief Financial Officer | Sell | $465K (3,403 @ $136.66) |
| Jul 2, 2018 | Michael J Doherty | Head of Product Development | Sell | $366K (2,675 @ $136.66) |
| Jul 2, 2018 | Vincent A. Miller | Chief Medical Officer | Sell | $398K (2,909 @ $136.66) |
| Jul 2, 2018 | Konstantin Fiedler | Chief Operating Officer | Sell | $136K (994 @ $136.66) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.